Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTIVADE: L-dopa/Carbidopa for Motivation and Motor Function in Major Depression
NCT05909267Recruiting
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levodopa and carbidopa in major depressive disorder (MDD) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Response bias in the Probabilistic Reward Task (PRT) at 48 hours and Mean gait speed in the dual task at 48 hours. Started Jul 2023; status: recruiting.
02
Drugs
levodopacarbidopa
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05909267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05909267.